Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Interest Expenses (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Interest Expenses for 10 consecutive years, with $64000.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 187.67% to $64000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $376000.0 through Dec 2025, up 683.33% year-over-year, with the annual reading at $376000.0 for FY2025, 683.33% up from the prior year.
  • Interest Expenses hit $64000.0 in Q4 2025 for Perspective Therapeutics, down from $65000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $128000.0 in Q1 2025 to a low of -$73000.0 in Q4 2024.
  • Historically, Interest Expenses has averaged $42166.7 across 3 years, with a median of $27500.0 in 2023.
  • Biggest five-year swings in Interest Expenses: tumbled 404.17% in 2024 and later skyrocketed 417.39% in 2025.
  • Year by year, Interest Expenses stood at $24000.0 in 2023, then crashed by 404.17% to -$73000.0 in 2024, then skyrocketed by 187.67% to $64000.0 in 2025.
  • Business Quant data shows Interest Expenses for CATX at $64000.0 in Q4 2025, $65000.0 in Q3 2025, and $119000.0 in Q2 2025.